1. Home
  2. STVN vs DINO Comparison

STVN vs DINO Comparison

Compare STVN & DINO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STVN
  • DINO
  • Stock Information
  • Founded
  • STVN 1949
  • DINO 1947
  • Country
  • STVN Italy
  • DINO United States
  • Employees
  • STVN N/A
  • DINO N/A
  • Industry
  • STVN Containers/Packaging
  • DINO Oil & Gas Production
  • Sector
  • STVN Consumer Discretionary
  • DINO Energy
  • Exchange
  • STVN Nasdaq
  • DINO Nasdaq
  • Market Cap
  • STVN 6.6B
  • DINO 6.2B
  • IPO Year
  • STVN 2021
  • DINO N/A
  • Fundamental
  • Price
  • STVN $22.14
  • DINO $36.12
  • Analyst Decision
  • STVN Buy
  • DINO Buy
  • Analyst Count
  • STVN 6
  • DINO 10
  • Target Price
  • STVN $25.08
  • DINO $44.89
  • AVG Volume (30 Days)
  • STVN 326.1K
  • DINO 2.7M
  • Earning Date
  • STVN 05-08-2025
  • DINO 05-01-2025
  • Dividend Yield
  • STVN 0.27%
  • DINO 5.54%
  • EPS Growth
  • STVN N/A
  • DINO N/A
  • EPS
  • STVN 0.50
  • DINO N/A
  • Revenue
  • STVN $1,215,562,040.00
  • DINO $27,923,000,000.00
  • Revenue This Year
  • STVN $8.42
  • DINO N/A
  • Revenue Next Year
  • STVN $10.44
  • DINO $1.64
  • P/E Ratio
  • STVN $44.76
  • DINO N/A
  • Revenue Growth
  • STVN 3.81
  • DINO N/A
  • 52 Week Low
  • STVN $16.56
  • DINO $24.66
  • 52 Week High
  • STVN $25.75
  • DINO $55.24
  • Technical
  • Relative Strength Index (RSI)
  • STVN 46.39
  • DINO 60.89
  • Support Level
  • STVN $21.97
  • DINO $35.41
  • Resistance Level
  • STVN $24.43
  • DINO $36.81
  • Average True Range (ATR)
  • STVN 1.28
  • DINO 1.03
  • MACD
  • STVN -0.21
  • DINO -0.07
  • Stochastic Oscillator
  • STVN 7.67
  • DINO 57.82

About STVN Stevanato Group S.p.A.

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.

About DINO HF Sinclair Corporation

HF Sinclair is an integrated petroleum refiner that owns and operates seven refineries serving the Rockies, midcontinent, Southwest, and Pacific Northwest, with a total crude oil throughput capacity of 678,000 barrels per day. It can produce 380 million gallons of renewable diesel annually. It holds a marketing business with over 300 distributors and 1,500 wholesale branded sites across 30 states. It also owns and operates 4,400 miles of petroleum product pipelines and terminals principally in the southwestern United States.

Share on Social Networks: